Liposome-based delivery system for vaccine candidates: constructing an effective formulation

Area of Science:

• Biotechnology
• Nanotechnology
• Immunology

Background:

• Liposomes, discovered in 1965, are nano- or micro-sized vesicles composed of phospholipid bilayers.
• They serve as versatile carriers for bioactive molecules in drug and vaccine delivery systems.
• Liposomes are generally non-immunogenic, necessitating combination with adjuvants or specific formulations for vaccine applications.

Purpose of the Study:

• To provide an overview of factors influencing liposomal immunogenicity in vaccine delivery.
• To detail how formulation parameters can be manipulated to design effective liposomal vaccine systems.

Main Methods:

• Review of existing literature on liposomal vaccine delivery systems.
• Analysis of the impact of specific formulation parameters on liposomal immunogenicity.

Main Results:

• Key formulation parameters influencing liposomal immunogenicity include vesicle size, surface charge, bilayer composition, and lamellarity.
• Surface modification techniques such as pegylation and targeted ligand coupling also affect immune responses.
• Understanding these parameters is crucial for designing robust and effective liposomal vaccine formulations.

Conclusions:

• The rational design of liposomal vaccine delivery systems relies on a comprehensive understanding of formulation-dependent immunogenicity.
• Optimizing parameters like vesicle size, charge, and composition can enhance vaccine efficacy.
• Further research into tailoring liposomal properties holds promise for next-generation vaccines.